FTO in Lung Cancer: Its Progression and Therapeutic Potential

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Lung cancer is a leading cause of cancer mortality worldwide.
• Its development involves complex genetic and multifactorial interactions.
• RNA N6-methyladenosine transferase (FTO) is emerging as a significant factor in cancer research.

Purpose of the Study:

• To provide an overview of the relationship between FTO and lung cancer.
• To discuss the mechanisms underlying FTO's involvement in lung cancer.
• To explore the potential clinical applications of FTO in lung cancer treatment.

Main Methods:

• Literature review of recent studies on FTO and lung cancer.
• Analysis of FTO's role in RNA methylation and metabolism.
• Examination of FTO's influence on tumor cell growth, proliferation, and metastasis.

Main Results:

• FTO, the first identified RNA demethylase, influences target mRNA demethylation.
• Imbalances in m6A methylation regulatory proteins, including FTO, disrupt RNA metabolism.
• FTO significantly impacts tumor cell progression and metastasis in lung cancer.

Conclusions:

• FTO is implicated in the development and progression of lung cancer.
• Understanding FTO's mechanisms offers potential therapeutic targets.
• Further research into FTO's clinical applications is warranted for lung cancer management.